SU1598873A3 - Способ получени производных хинолина или их фармацевтически приемлемых сложных эфиров или фармацевтически приемлемых аддитивных солей кислоты - Google Patents

Способ получени производных хинолина или их фармацевтически приемлемых сложных эфиров или фармацевтически приемлемых аддитивных солей кислоты Download PDF

Info

Publication number
SU1598873A3
SU1598873A3 SU874203548A SU4203548A SU1598873A3 SU 1598873 A3 SU1598873 A3 SU 1598873A3 SU 874203548 A SU874203548 A SU 874203548A SU 4203548 A SU4203548 A SU 4203548A SU 1598873 A3 SU1598873 A3 SU 1598873A3
Authority
SU
USSR - Soviet Union
Prior art keywords
group
methyl
hydrogen atom
formula
pharmaceutically acceptable
Prior art date
Application number
SU874203548A
Other languages
English (en)
Russian (ru)
Inventor
Мацумото Юн-Ичи
Миямото Теруюки
Эгава Хироси
Накамура Синичи
Original Assignee
Дайниппон Фармасьютикал Ко,Лтд (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дайниппон Фармасьютикал Ко,Лтд (Фирма) filed Critical Дайниппон Фармасьютикал Ко,Лтд (Фирма)
Application granted granted Critical
Publication of SU1598873A3 publication Critical patent/SU1598873A3/ru
Priority to LV930262A priority Critical patent/LV5479A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SU874203548A 1985-10-29 1987-10-27 Способ получени производных хинолина или их фармацевтически приемлемых сложных эфиров или фармацевтически приемлемых аддитивных солей кислоты SU1598873A3 (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
LV930262A LV5479A3 (lv) 1985-10-29 1993-04-23 Hinolina atvasinajumu vai to farmaceitiski pienemamu esteru vai farmaceitiski pienemamu skabes aditivo salu iegusanas metode

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP24225785 1985-10-29
JP28532385 1985-12-17
JP3262786 1986-02-17

Publications (1)

Publication Number Publication Date
SU1598873A3 true SU1598873A3 (ru) 1990-10-07

Family

ID=27287785

Family Applications (2)

Application Number Title Priority Date Filing Date
SU874203544A SU1635898A3 (ru) 1985-10-29 1987-10-27 Способ получени производных хинолина или их фармацевтически приемлемых сложных эфиров, или фармацевтически приемлемых солей указанных производных или сложных эфиров
SU874203548A SU1598873A3 (ru) 1985-10-29 1987-10-27 Способ получени производных хинолина или их фармацевтически приемлемых сложных эфиров или фармацевтически приемлемых аддитивных солей кислоты

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SU874203544A SU1635898A3 (ru) 1985-10-29 1987-10-27 Способ получени производных хинолина или их фармацевтически приемлемых сложных эфиров, или фармацевтически приемлемых солей указанных производных или сложных эфиров

Country Status (26)

Country Link
US (1) US4795751A (WO2006108709A1)
EP (2) EP0375658B1 (WO2006108709A1)
JP (2) JPS62277362A (WO2006108709A1)
KR (1) KR910006806B1 (WO2006108709A1)
CN (1) CN1009930B (WO2006108709A1)
AR (3) AR242031A1 (WO2006108709A1)
AT (2) ATE109472T1 (WO2006108709A1)
AU (1) AU594983B2 (WO2006108709A1)
CA (1) CA1340402C (WO2006108709A1)
DE (3) DE3650018T2 (WO2006108709A1)
DK (2) DK170593B1 (WO2006108709A1)
ES (2) ES2057197T3 (WO2006108709A1)
FI (1) FI87457C (WO2006108709A1)
GE (1) GEP19960467B (WO2006108709A1)
GR (1) GR3002475T3 (WO2006108709A1)
HU (1) HU200452B (WO2006108709A1)
IL (1) IL80404A (WO2006108709A1)
LU (2) LU88596I2 (WO2006108709A1)
MY (1) MY100574A (WO2006108709A1)
NL (2) NL970020I2 (WO2006108709A1)
NO (1) NO170726C (WO2006108709A1)
NZ (1) NZ218089A (WO2006108709A1)
PH (1) PH22862A (WO2006108709A1)
PT (1) PT83643B (WO2006108709A1)
SU (2) SU1635898A3 (WO2006108709A1)
YU (3) YU46414B (WO2006108709A1)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977154A (en) * 1985-12-12 1990-12-11 Warner-Lambert Company 5-amino and 5-hydroxy-6-fluoroquinolones as antibacterial agents
EP0242789A3 (en) * 1986-04-25 1990-09-05 Dainippon Pharmaceutical Co., Ltd. Novel quinoline derivates and processes for preparation thereof
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
US5563138A (en) * 1987-04-16 1996-10-08 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
US4780468A (en) * 1987-08-07 1988-10-25 Warner-Lambert Company 8-trifluoromethyl quinolones as antibacterial agents
US5164392A (en) * 1987-10-16 1992-11-17 Dainippon Pharmaceutical Co., Ltd. Quinoline derivatives and antibacterial agent containing them
IL88003A (en) * 1987-10-16 1992-11-15 Dainippon Pharmaceutical Co Quinoline derivatives,their preparation and pharmaceutical compositions containing them
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
JPH0674261B2 (ja) * 1988-06-21 1994-09-21 塩野義製薬株式会社 キノロンカルボン酸誘導体
JP2709604B2 (ja) * 1988-06-29 1998-02-04 大日本製薬株式会社 マイコプラズマ汚染の防止または除去
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
FR2655545B1 (fr) 1989-12-11 1994-06-10 Rhone Poulenc Sante Nouvelle application therapeutique des derives des fluoroquinolones.
DE4019023A1 (de) * 1990-06-14 1991-12-19 Bayer Ag Verfahren zur herstellung von chinolincarbonsaeuren
JP2613139B2 (ja) * 1990-07-19 1997-05-21 エスエス製薬 株式会社 キノロンカルボン酸誘導体
US5342846A (en) * 1990-12-05 1994-08-30 Synphar Laboratories, Inc. 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds and 7-(substituted triazolyl pyrrolidin-1-yl) 4-oxoquinoline-3-carboxylic acid derivatives useful as antibacterial agents
FR2681863B1 (fr) * 1991-09-27 1995-02-03 Rhone Dpc Europ Solution de sparfloxacine sa preparation et sel la constituant.
EP0601197A4 (en) * 1992-05-26 1994-10-26 Ss Pharmaceutical Co DERIVATIVES OF 5-AMINOCHINOLONE CARBOXYLIC ACID AND ANTIBACTERIAL AGENTS CONTAINING IT AS AN ACTIVE INGREDIENT.
WO1993025545A1 (en) * 1992-06-09 1993-12-23 Korea Research Institute Of Chemical Technology Novel quinoline derivatives and processes for preparing the same
US5290794A (en) * 1992-10-27 1994-03-01 Warner Lambert Co. Soluble calcium lactate antibacterial complexes as non-irritating parenteral forms
US5646163A (en) * 1992-10-30 1997-07-08 The Procter & Gamble Company Quinolone 5-(N-heterosubstituted amino) antimicrobials
CN1038326C (zh) * 1993-07-20 1998-05-13 爱斯制药株式会社 5－氨基喹诺酮羧酸衍生物及其含有该衍生物作为活性成分的抗菌剂
US5532239A (en) * 1993-08-02 1996-07-02 Assistance Publique - Hopitaux De Paris Therapeutic application of fluoroquinolone derivatives
AU757777B2 (en) 1998-12-04 2003-03-06 Influx, Inc. Inhibitors of multidrug transporters
KR100768034B1 (ko) 1999-03-17 2007-10-17 다이이찌 세이야꾸 가부시기가이샤 의약 조성물
CN1091103C (zh) * 1999-04-02 2002-09-18 中国科学院上海药物研究所 一类喹诺酮类化合物及它的制备和其用途
US6957105B2 (en) * 2002-03-26 2005-10-18 Cardiac Pacemakers, Inc. Method and apparatus for detecting oscillations in cardiac rhythm with electrogram signals
KR100519158B1 (ko) * 2002-12-21 2005-10-06 주식회사유한양행 퀴놀론 카르복실레이트 유도체의 제조방법
US20070197548A1 (en) 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
US7973022B2 (en) 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
US20070196398A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone fatty acid salt compositions
US20080139574A1 (en) 2006-11-30 2008-06-12 Cadila Healthcare Limited Novel quinoline derivatives
CN117899079A (zh) 2017-06-22 2024-04-19 希普拉有限公司 癌症的治疗方法
CN112939860B (zh) * 2019-11-11 2022-11-11 山东畜牧兽医职业学院 一种治疗耐药性革兰阴阳性菌的化合物及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3753993A (en) * 1971-05-17 1973-08-21 Sterling Drug Inc 1,4-dihydro-4-oxo-7-pyridyl-3-quinoline-carboxylic acid derivatives
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
JPS58174367A (ja) 1982-04-07 1983-10-13 Tanabe Seiyaku Co Ltd キノリン誘導体及びその製法
DE3248506A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7(alkyl-1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3248507A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen Mikrobizide mittel auf chinoloncarbonsaeure basis
DE3306771A1 (de) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen Chinoloncarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
CS274601B2 (en) * 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
JPS60169475A (ja) * 1984-02-14 1985-09-02 Dai Ichi Seiyaku Co Ltd キノリン誘導体
EP0160578B1 (en) * 1984-02-17 1989-11-23 Daiichi Seiyaku Co., Ltd. 1,8-naphthyridine derivatives
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
ZA852369B (en) 1984-04-26 1985-12-24 Abbott Lab Quinoline antibacterial compounds
DE3420743A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3420798A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-(3-aryl-l-piperazinyl)- sowie 7-(3-cyclohexyl-l-piperazinyl)-3-chinoloncarbonsaeuren
JPS6110574A (ja) * 1984-06-25 1986-01-18 Hokuriku Seiyaku Co Ltd ６−フルオロ−１，４−ジヒドロ−４−オキソ−７−置換ピペラジニルキノリン−３−カルボン酸誘導体
IE58742B1 (en) 1984-07-20 1993-11-05 Warner Lambert Co Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
JPS6191183A (ja) * 1984-10-11 1986-05-09 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
EP0181521A1 (en) * 1984-10-19 1986-05-21 Otsuka Pharmaceutical Co., Ltd. Antimicrobial 1-substituted Phenyl-4-oxoquinoline-3-carboxylic acid compounds
US4636506A (en) * 1984-12-06 1987-01-13 Pfizer, Inc. 7-heterocyclic-1,4-dihydroquinolones
JPS6212760A (ja) * 1984-12-14 1987-01-21 Dai Ichi Seiyaku Co Ltd １−（２−ハロゲノシクロプロピル）キノリンカルボン酸誘導体
US4657913A (en) * 1985-04-18 1987-04-14 Warner-Lambert Company Trifluoro- quinoline -3- carboxylic acids and their use as anti-bacterial agents
JPS6259263A (ja) * 1985-09-10 1987-03-14 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
US4668680A (en) * 1985-12-12 1987-05-26 Warner-Lambert Company 5-amino-6,8-difluoroquinolones as antibacterial agents
US4977154A (en) * 1985-12-12 1990-12-11 Warner-Lambert Company 5-amino and 5-hydroxy-6-fluoroquinolones as antibacterial agents
EP0230053A3 (en) * 1986-01-17 1988-03-30 American Cyanamid Company 7-(substituted)piperazinyl-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
EP0242789A3 (en) * 1986-04-25 1990-09-05 Dainippon Pharmaceutical Co., Ltd. Novel quinoline derivates and processes for preparation thereof
GB8612137D0 (en) * 1986-05-19 1986-06-25 Fujisawa Pharmaceutical Co Quinolone compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Бюлер К., Пирсон Д. Органические синтезы, ч. 1. - М.: Мир, 1973, . . . с. 504. (.54) СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНЫХ ХИНОЛИНА ИЛИ ИХ ФАРМАЦЕВТИЧЕСКИ ПРИЕМЛЕМЫХ СЛОЖНЫХ ЭФИРОВ ИЛИ ФАРМАЦЕВ-.. ТИЧЕСКИ ПРИЕМЛЕМЫХ АДДИТИВНЫХ СОЛЕЙ КИСЛОТЫ *

Also Published As

Publication number Publication date
NO170726C (no) 1992-11-25
FI864299A (fi) 1987-04-30
FI87457C (fi) 1993-01-11
CN1009930B (zh) 1990-10-10
LU90621I2 (fr) 2000-10-09
US4795751A (en) 1989-01-03
JPS62277362A (ja) 1987-12-02
MY100574A (en) 1990-12-15
NZ218089A (en) 1989-03-29
NL970020I1 (nl) 1997-08-01
IL80404A0 (en) 1987-01-30
AU594983B2 (en) 1990-03-22
JPH0543551A (ja) 1993-02-23
CA1340402C (en) 1999-02-23
SU1635898A3 (ru) 1991-03-15
JPH0714918B2 (ja) 1995-02-22
HU200452B (en) 1990-06-28
HUT43839A (en) 1987-12-28
KR910006806B1 (ko) 1991-09-02
GEP19960467B (en) 1996-05-27
ATE109472T1 (de) 1994-08-15
IL80404A (en) 1990-06-10
DK514586A (da) 1987-04-30
YU137291A (sh) 1994-01-20
DE3650018D1 (de) 1994-09-08
PT83643A (en) 1986-11-01
EP0375658A1 (en) 1990-06-27
ATE66210T1 (de) 1991-08-15
DE10075028I2 (de) 2004-01-29
DE3650018T2 (de) 1995-01-05
EP0221463A3 (en) 1987-12-02
KR870004019A (ko) 1987-05-06
CN86107491A (zh) 1987-04-29
DK25992A (da) 1992-02-28
DK25992D0 (da) 1992-02-28
NL300014I2 (nl) 2001-02-01
AR243178A1 (es) 1993-07-30
YU137191A (sh) 1994-01-20
ES2057197T3 (es) 1994-10-16
AR242031A1 (es) 1993-02-26
AU6427786A (en) 1987-04-30
NO864247L (no) 1987-04-30
EP0375658B1 (en) 1994-08-03
JPH0541633B2 (WO2006108709A1) 1993-06-24
DE10075028I1 (de) 2000-12-14
GR3002475T3 (en) 1992-12-30
EP0221463A2 (en) 1987-05-13
DE3680859D1 (de) 1991-09-19
PT83643B (pt) 1988-10-14
YU183586A (en) 1988-04-30
NO864247D0 (no) 1986-10-23
NL970020I2 (nl) 1998-01-05
DK170593B1 (da) 1995-11-06
DK514586D0 (da) 1986-10-28
YU46414B (sh) 1993-10-20
FI87457B (fi) 1992-09-30
LU88596I2 (fr) 1995-07-10
AR243520A1 (es) 1993-08-31
DK170774B1 (da) 1996-01-15
PH22862A (en) 1989-01-19
EP0221463B1 (en) 1991-08-14
FI864299A0 (fi) 1986-10-23
ES2029786T3 (es) 1992-10-01
NO170726B (no) 1992-08-17
NL300014I1 (nl) 2000-10-02

Similar Documents

Publication Publication Date Title
SU1598873A3 (ru) Способ получени производных хинолина или их фармацевтически приемлемых сложных эфиров или фармацевтически приемлемых аддитивных солей кислоты
SU1588282A3 (ru) Способ получени производного хинолина, или его фармацевтически приемлемого сложного эфира, или фармацевтически приемлемых солей указанного производного или его эфира
EP0009425B1 (en) Novel naphtyridine derivatives and pharmaceutical compositions containing them
HU199821B (en) Process for production of derivatives of in 8 position substituated quinoline carbonic acid and medical compositions containing them
EP0109284B1 (en) 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1h,5h-benzo(ij)quinolizine-2-carboxylic acid and derivatives
SU1075976A3 (ru) Способ получени производных 1,8-нафтиридина или их солей
US4382937A (en) Naphthyridine derivatives and their use as anti-bacterials
KR900006741B1 (ko) 아제티디닐 퀴놀론 카복실산 및 에스테르
EP0181521A1 (en) Antimicrobial 1-substituted Phenyl-4-oxoquinoline-3-carboxylic acid compounds
JPS60126284A (ja) ピリドンカルボン酸誘導体およびその塩
RU2041226C1 (ru) Замещенные производные изотиазол-пиридон ацетидинила и фармацевтическая композиция на их основе
US4496566A (en) Naphthyridine derivatives
JPH0717609B2 (ja) ノルフロキサシンの水溶性付加物
SU1442075A3 (ru) Способ получени производных 1,8-нафтиридина или их солей
SU1456015A3 (ru) Способ получени производных 1,8-нафтиридина или их кислотно-аддитивных солей (его варианты)
US4720495A (en) Benzo[ij]quinolizine-2-carboxylic acids useful for treating bacterial infection
US6822098B2 (en) Ester or amide derivatives
EP0364943A2 (en) Benzoheterocyclic compounds
JPS58174367A (ja) キノリン誘導体及びその製法
CA2102196A1 (en) 5-aminoquinolone carboxylic acid derivative and antibacterial agent containing the same as active ingredient
KR0166179B1 (ko) 새로운 퀴놀론 카르복실산 유도체 및 그 제조방법
SU1029829A3 (ru) Способ получени производных 1,8-нафтиридина или их фармацевтически пригодных солей
JPS6270370A (ja) キノロンカルボン酸誘導体およびその製造方法
SU1519529A3 (ru) Способ получени производного хинолина, его фармацевтически приемлемого сложного эфира или фармацевтически приемлемой соли производного хинолина или сложного эфира
WO1991016311A1 (en) 7-(substituted hydrazino)-4-oxoquinoline-3-carboxylic acid derivative, its salt and its ester

Legal Events

Date Code Title Description
REG Reference to a code of a succession state

Ref country code: RU

Ref legal event code: MM4A

Effective date: 20041028